Clinical trial
A Study to Evaluate the Safety, and Efficacy of Minimally Manipulated Autologous Bone Marrow Aspirate to Treat Knee Osteoarthritis in Patients
NCT05288725 is registered in ClinicalTrials.gov with Next Generation Regenerative Medicine LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study to Evaluate the Safety, and Efficacy of Minimally Manipulated Autologous Bone Marrow Aspirate to Treat Knee Osteoarthritis in Patients
- Lead sponsor
- Next Generation Regenerative Medicine LLC
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- August 31, 2022
- Completion date
- December 31, 2024
- Enrollment
- 120 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.